Literature DB >> 15509825

Genomics and malaria control.

Kenneth D Vernick1, Andrew P Waters.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15509825     DOI： 10.1056/NEJMcibr042899

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  5 in total

1.  Potencies of human immunodeficiency virus protease inhibitors in vitro against Plasmodium falciparum and in vivo against murine malaria.

Authors:  Katherine T Andrews; David P Fairlie; Praveen K Madala; John Ray; David M Wyatt; Petrina M Hilton; Lewis A Melville; Lynette Beattie; Donald L Gardiner; Robert C Reid; Martin J Stoermer; Tina Skinner-Adams; Colin Berry; James S McCarthy
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

Review 2.  Transmission-Blocking Vaccines: Focus on Anti-Vector Vaccines against Tick-Borne Diseases.

Authors:  Girish Neelakanta; Hameeda Sultana
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2014-12-12       Impact factor: 4.291

Review 3.  RNA interference: from gene silencing to gene-specific therapeutics.

Authors:  Ray K M Leung; Paul A Whittaker
Journal:  Pharmacol Ther       Date:  2005-08       Impact factor: 12.310

4.  Anopheles gambiae APL1 is a family of variable LRR proteins required for Rel1-mediated protection from the malaria parasite, Plasmodium berghei.

Authors:  Michelle M Riehle; Jiannong Xu; Brian P Lazzaro; Susan M Rottschaefer; Boubacar Coulibaly; Madjou Sacko; Oumou Niare; Isabelle Morlais; Sekou F Traore; Kenneth D Vernick
Journal:  PLoS One       Date:  2008-11-07       Impact factor: 3.240

5.  Microbial Pre-exposure and Vectorial Competence of Anopheles Mosquitoes.

Authors:  Constentin Dieme; Brice Rotureau; Christian Mitri
Journal:  Front Cell Infect Microbiol       Date:  2017-12-07       Impact factor: 5.293
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.